The Lifesciences Magazine

  3 Lifesciences Firms that are Overcoming Unique Challenges By The Lifesciences Magazine INTRODUCTION J.P. Morgan’s Life Sciences bankers are contributing to the success of cutting-edge enterprises of all stages, from start-ups to businesses on the verge of commercialization. Discover how three very distinct lifesciences firms industry are achieving growth while operating in an FDA regulatory climate that is becoming more difficult. Here are 3 Lifesciences Firms that are Overcoming Unique Challenges; 1. Amring Amring Medications is a privately owned firm that began operations in 2015 with the goal of developing, manufacturing, and marketing generic pharmaceuticals for specialized markets. Amring is a partner with a network of multinational biopharmaceutical businesses and has its headquarters in Berwyn, Pennsylvania, which is located just outside of Philadelphia. Despite the fact that Amring is a young company, it generated more than $30 million in revenue in 2016, and it is now p...

10 Strategies for Clinical Trials Recruitment Marketing By The Lifesciences Magazine Strong recruiting techniques and Strategies for Clinical Trials begin with the patient as the center of attention and use a range of outreach approaches that are aimed to educate and engage prospective participants. Before beginning outreach, it is a good idea to establish a systematic strategy for the recruitment of clinical trial participants. This is a smart method to guarantee that the process is organized, and productive, and places the utmost importance on the patient experience. When it comes to recruiting for clinical research, speed is key in addition to putting the patient’s needs first. It is estimated that a delay in the development of a drug can cost sponsors approximately $37,000 per day in operational costs and $600,000 to $8M per day in opportunity costs. It can be extremely important for patients who are dealing with serious conditions to gain access to a more effective treatment optio...